Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review
Crossref DOI link: https://doi.org/10.1007/s12325-022-02169-3
Published Online: 2022-06-14
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jhalani, Nisha B.
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2022-06-14
Version of Record valid from 2022-06-14
Article History
Received: 2 March 2022
Accepted: 14 April 2022
First Online: 14 June 2022